Literature DB >> 10654658

Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).

T Sagvolden1.   

Abstract

A good model of a disorder is one that: (a) mimics, although in a simpler form than the full-blown clinical case, the fundamentals of the behavioral characteristics, in this case of people with Attention-Deficit/Hyperactivity Disorder (AD/HD;face validity); (b) conforms with a theoretical rationale for the disorder (construct validity); and (c) is able to predict aspects of behavior, genetics and neurobiology previously uncharted in the clinics (predictive validity). This article discusses the Spontaneously Hypertensive Rat (SHR) and some other putative animal models of AD/HD. It is argued that although other strains and species may be hyperactive and/or show attention deficits following genetic, environmental or pharmacological interventions, the SHR is presently the only strain shown to have the major behavioral symptoms of AD/HD. This does not mean that investigating other models cannot give valuable information.

Entities:  

Mesh:

Year:  2000        PMID: 10654658     DOI: 10.1016/s0149-7634(99)00058-5

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  144 in total

1.  Differential expression of SLC9A9 and interacting molecules in the hippocampus of rat models for attention deficit/hyperactivity disorder.

Authors:  Yanli Zhang-James; Frank A Middleton; Terje Sagvolden; Stephen V Faraone
Journal:  Dev Neurosci       Date:  2012-07-06       Impact factor: 2.984

2.  Chronic methylphenidate treatment during early life is associated with greater ethanol intake in socially isolated rats.

Authors:  Kathryn E Gill; Ann M Chappell; Thomas J R Beveridge; Linda J Porrino; Jeffrey L Weiner
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

3.  Individual and combined effects of physical exercise and methylphenidate on orienting behavior and social interaction in spontaneously hypertensive rats.

Authors:  Andrea M Robinson; David J Bucci
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

4.  Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2006-10-19       Impact factor: 4.077

5.  Impaired Energy Metabolism and Disturbed Dopamine and Glutamate Signalling in the Striatum and Prefrontal Cortex of the Spontaneously Hypertensive Rat Model of Attention-Deficit Hyperactivity Disorder.

Authors:  Jacqueline J Dimatelis; Jennifer H Hsieh; Toni-Lee Sterley; Lelanie Marais; Jacqueline S Womersley; Maré Vlok; Vivienne A Russell
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

Review 6.  How early media exposure may affect cognitive function: A review of results from observations in humans and experiments in mice.

Authors:  Dimitri A Christakis; Julian S Benedikt Ramirez; Susan M Ferguson; Shilpa Ravinder; Jan-Marino Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-02       Impact factor: 11.205

7.  The Investigation of Symptoms and Diagnoses of Adult-Attention Deficit/ Hyperactivity Disorder in Women with Iron Deficiency Anemia.

Authors:  Kadir Demirci; Funda Yildirim Baş; Bahriye Arslan; Zeliha Salman; Abdullah Akpinar; Arif Demirdaş
Journal:  Noro Psikiyatr Ars       Date:  2016-03-04       Impact factor: 1.339

8.  Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.

Authors:  Heleen Suzanne Soeters; Fleur Margaret Howells; Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2008-07-30       Impact factor: 3.584

9.  Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects.

Authors:  Emily Carias; Dennis Fricke; Abisha Vijayashanthar; Lauren Smith; Rathini Somanesan; Connor Martin; Leanna Kalinowski; Daniel Popoola; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos
Journal:  Behav Brain Res       Date:  2018-08-24       Impact factor: 3.332

10.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.